Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-14

Clinical Trial Update: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lacosamide as add-on therapy for epileptic tonic-clonic seizures; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2023-12-14